| For: | Ho JW, Poon RT, Sun CK, Xue WC, Fan ST. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol 2005; 11(2): 176-181 [PMID: 15633211 DOI: 10.3748/wjg.v11.i2.176] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/176.htm |
| Number | Citing Articles |
| 1 |
Amol Ramchandra Gadbail, Mugdha P. Mankar (Gadbail), Alka Hande, Minal S. Chaudhary, Shailesh M. Gondivkar, Sheetal Korde, Madhuri N. Gawande, Swati Patil, Satyjitraje Tekade, Aparna Sharma. Tumor angiogenesis: Role in locally aggressive biological behavior of ameloblastoma and keratocystic odontogenic tumor. Head & Neck 2013; 35(3) doi: 10.1002/hed.22960
|
| 2 |
Dimitrios Lytras, Vassileia Leontara, Maria Kefala, Periklis G. Foukas, Niki Giannakou, Abraham Pouliakis, Christos Dervenis, Ioannis G. Panayiotides, Petros Karakitsos. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma. Pancreas 2015; 44(1) doi: 10.1097/MPA.0000000000000197
|
| 3 |
Qi Zhang, Jiajun Wu, Xueli Bai, Tingbo Liang. Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.584250
|
| 4 |
Keigo Murakami, Atsuko Kasajima, Naoki Kawagishi, Satoshi Sekiguchi, Fumiyoshi Fujishima, Mika Watanabe, Yasufumi Sato, Noriaki Ohuchi, Hironobu Sasano. The prognostic significance of vasohibin 1–associated angiogenesis in patients with hepatocellular carcinoma. Human Pathology 2014; 45(3) doi: 10.1016/j.humpath.2013.10.028
|
| 5 |
Alessia Virzì, Armando Andres Roca Suarez, Thomas F. Baumert, Joachim Lupberger. Oncogenic Signaling Induced by HCV Infection. Viruses 2018; 10(10) doi: 10.3390/v10100538
|
| 6 |
Toshitsugu Nakamura. Changes in Expression of Bile Canalicular CD10 and Sinusoidal CD105 (Endoglin) in Peritumoral Hepatic Tissue. Tumori Journal 2009; 95(4) doi: 10.1177/030089160909500415
|
| 7 |
Kuo-Shyang Jeng, I-Shyan Sheen, Shu-Sheng Lin, Chuen-Miin Leu, Chiung-Fang Chang. The Role of Endoglin in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(6) doi: 10.3390/ijms22063208
|
| 8 |
Vanderlei Segatelli, Ebe Christie de Oliveira, Ilka F. S. F. Boin, Elaine Cristina Ataide, Cecilia Amelia F. Escanhoela. Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinoma. Hepatology International 2014; doi: 10.1007/s12072-014-9525-9
|
| 9 |
M. A. Abdelwa, M. M. Elbedew, A. M. Amin, A. K. Tawfik. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients. Research Journal of Immunology 2016; 10(1) doi: 10.3923/rji.2017.1.7
|
| 10 |
Gabriel Corteze Netto, Cristina Birlem Bleil, Arlete Hilbig, Lígia Maria Barbosa Coutinho. Immunohistochemical evaluation of the microvascular density through the expression of TGF‐β (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Neuropathology 2008; 28(1) doi: 10.1111/j.1440-1789.2007.00825.x
|
| 11 |
|
| 12 |
Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustín Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. European Journal of Gastroenterology & Hepatology 2014; 26(8) doi: 10.1097/MEG.0000000000000131
|
| 13 |
A. I. Shchyogolev, E. A. Dubova, U. N. Tumanova. Vascularization of Hepatocellular Carcinoma Tissue Depends on Its Differentiation Degree. Bulletin of Experimental Biology and Medicine 2012; 153(4) doi: 10.1007/s10517-012-1749-x
|
| 14 |
Chang-Cheng Zhao, Wen-Wei Yu, Ying-Jie Qi, Liang-Fei Xu, Zi-Ran Wang, Ya-Wen Qiang, Fan Ma, Xiao-Ling Ma. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells. Anti-Cancer Drugs 2020; 31(3) doi: 10.1097/CAD.0000000000000866
|
| 15 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2) doi: 10.1016/j.critrevonc.2011.05.005
|
| 16 |
Yamato Ninomiya, Soji Ozawa, Junya Oguma, Akihito Kazuno, Miho Nitta, Hiroshi Kajiwara, Yasufumi Sato. Expression of vasohibin‑1 and ‑2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus. Oncology Letters 2018; doi: 10.3892/ol.2018.9249
|
| 17 |
Kenichirou Kato, Tadahiro Takada, Toshio Fukusato. Expression of vascular endothelial‐cadherin in human hepatocellular carcinoma tissues. Hepatology Research 2007; 37(6) doi: 10.1111/j.1872-034X.2007.00051.x
|
| 18 |
Decai Yu, Linyuan Zhuang, Xitai Sun, Jun Chen, Yongzhong Yao, Kui Meng, Yitao Ding. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer 2007; 7(1) doi: 10.1186/1471-2407-7-122
|
| 19 |
Ruixia Xie, Xiaoying Wang, Guoqing Qi, Zhiping Wu, Rong Wei, Peirong Li, Dekui Zhang. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition. Tumor Biology 2016; 37(9) doi: 10.1007/s13277-016-5070-6
|
| 20 |
Hideyuki Yoshitomi, Souichi Kobayashi, Masayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masaru Miyazaki. Specific Expression of Endoglin (CD105) in Endothelial Cells of Intratumoral Blood and Lymphatic Vessels in Pancreatic Cancer. Pancreas 2008; 37(3) doi: 10.1097/mpa.0b013e3181690b97
|
| 21 |
. 2019; doi: 10.70675/ddbff38dza323z44b2za1ddzc96f4d14950e
|
| 22 |
Young-Chan Kwon, Reina Sasaki, Keith Meyer, Ranjit Ray, J.-H. James Ou. Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis. Journal of Virology 2017; 91(21) doi: 10.1128/JVI.01235-17
|
| 23 |
Aldona Kasprzak, Agnieszka Adamek. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123887
|
| 24 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6) doi: 10.1016/j.ejca.2007.01.004
|
| 25 |
Noel Weidner. Angiogenesis: In Vivo Systems, Part A. Methods in Enzymology 2008; 444 doi: 10.1016/S0076-6879(08)02814-0
|
| 26 |
De-Cai Yu, Jun Chen, Yi-Tao Ding. Hypoxic and Highly Angiogenic Non-Tumor Tissues Surrounding Hepatocellular Carcinoma: The ‘Niche’ of Endothelial Progenitor Cells. International Journal of Molecular Sciences 2010; 11(8) doi: 10.3390/ijms11082901
|
| 27 |
Madhu Shree Poddar, Yu-De Chu, Chau-Ting Yeh, Cheng-Hsien Liu. Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms. Lab on a Chip 2024; 24(15) doi: 10.1039/D4LC00238E
|
| 28 |
Juliana Passos Paschoal, Vagner Bernardo, Nathalie Henriques Silva Canedo, Osmar Damasceno Ribeiro, Adriana Caroli-Bottino, Vera Lucia Pannain. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-72
|
| 29 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_186-1
|
| 30 |
Ester Fonsatti, Michele Maio. Transforming Growth Factor-β in Cancer Therapy, Volume I. 2008; doi: 10.1007/978-1-59745-292-2_25
|
| 31 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6) doi: 10.1002/ar.20668
|
| 32 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
| 33 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_6-1
|
| 34 |
Anna Benetti, Angiola Berenzi, Marco Gambarotti, Emirena Garrafa, Maurizio Gelati, Enrico Dessy, Nazario Portolani, Tullio Piardi, Stefano Maria Giulini, Arnaldo Caruso, Gloria Invernici, Eugenio Agostino Parati, Roberto Nicosia, Giulio Alessandri. Transforming Growth Factor-β1 and CD105 Promote the Migration of Hepatocellular Carcinoma–Derived Endothelium. Cancer Research 2008; 68(20) doi: 10.1158/0008-5472.CAN-08-1218
|
| 35 |
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis. Scandinavian Journal of Gastroenterology 2009; 44(9) doi: 10.1080/00365520903121685
|
| 36 |
Eray Yagmur, Mohamed Rizk, Sven Stanzel, Claus Hellerbrand, Frank Lammert, Christian Trautwein, Hermann E. Wasmuth, Axel M. Gressner. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma. European Journal of Gastroenterology & Hepatology 2007; 19(9) doi: 10.1097/MEG.0b013e3282202bea
|
| 37 |
Amit Nair, Nicola Ingram, Eldo T. Verghese, Imeshi Wijetunga, Alexander F. Markham, Judy Wyatt, K. Rajendra Prasad, P. Louise Coletta. CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma. Cellular Oncology 2020; 43(5) doi: 10.1007/s13402-020-00530-8
|
| 38 |
Hiroaki Kobayashi, Takeo Kosaka, Shuji Mikami, Tokuhiro Kimura, Hiroshi Hongo, Michio Kosugi, Yasufumi Sato, Mototsugu Oya. Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan. BMJ Open 2021; 11(11) doi: 10.1136/bmjopen-2021-056439
|
| 39 |
Keigo Murakami, Atsuko Kasajima, Naoki Kawagishi, Noriaki Ohuchi, Hironobu Sasano. Microvessel density in hepatocellular carcinoma: Prognostic significance and review of the previous published work. Hepatology Research 2015; 45(12) doi: 10.1111/hepr.12487
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_6
|
| 41 |
Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. Clinics 2016; 71(11) doi: 10.6061/clinics/2016(11)04
|
| 42 |
Zhao-You Tang, Lun-Xiu Qin, Hui-Chuan Sun, Qing-Hai Ye. Molecular Genetics of Liver Neoplasia. 2010; doi: 10.1007/978-1-4419-6082-5_19
|
| 43 |
Alka H. Hande, Amol R. Gadbail, Archana M. Sonone, Minal S. Chaudhary, Vijay Wadhwan, Atul Nikam. Comparative analysis of tumour angiogenesis in solid multicystic and unicystic ameloblastoma by using CD 105 (endoglin). Archives of Oral Biology 2011; 56(12) doi: 10.1016/j.archoralbio.2011.06.007
|
| 44 |
A. I. Shchyogolev, U. N. Tumanova, E. A. Dubova. Morphometric Evaluation of Vascularization of Hepatic Focal Nodular Hyperplasia. Bulletin of Experimental Biology and Medicine 2013; 156(2) doi: 10.1007/s10517-013-2327-6
|
| 45 |
Hongyan Qian, Liping Yang, Wenjing Zhao, Haizhen Chen, Song He. A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6553
|
| 46 |
Xing Gu, Xin Ji, Le-Hua Shi, Chang-Hong Yi, Yun-Peng Zhao, Ai-Hua Wang, Lun-Gen Lu, Wen-Bo Yu, Chun-Fang Gao. Transforming Growth Factor beta1 Gene Variation Leu10Pro Affects Secretion and Function in Hepatic Cells. Digestive Diseases and Sciences 2012; 57(11) doi: 10.1007/s10620-012-2238-9
|
| 47 |
Yu-Quan Xiong, Hui-Chuan Sun, Wei Zhang, Xiao-Dong Zhu, Peng-Yuan Zhuang, Ju-Bo Zhang, Lu Wang, Wei-zhong Wu, Lun-Xiu Qin, Zhao-You Tang. Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells. Clinical Cancer Research 2009; 15(15) doi: 10.1158/1078-0432.CCR-08-2780
|
| 48 |
Desong Xia, Xiyu Liu, Yuhan Liao, Huiling Wang, Yanmei Li, Jian He, Jing Zhang, Liping Zhong, Yuhuan Wang. Detection of Hepatoma Serum Marker CD105 with Hemin/Graphene/Aptamer Nanoprobes. Journal of Biomedical Nanotechnology 2024; 20(3) doi: 10.1166/jbn.2024.3791
|
| 49 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_186
|
| 50 |
Nausathkhan Ubayathulla, M.R. Muthusekar, Abilasha Ramasubramanian, Kavya Dharmaraj. COMPARATIVE EVALUATION OF ENDOGLIN EXPRESSION IN AMELOBLASTOMA, ODONTOGENIC KERATOCYST, AND DENTIGEROUS CYST: AN INSTITUTIONAL STUDY WITH A COMPREHENSIVE LITERATURE REVIEW. BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY 2025; doi: 10.58240/1829006X-2025.21.8-454
|
| 51 |
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 2006; 242(2) doi: 10.1016/j.canlet.2006.01.008
|
| 52 |
Jung Woo Eun, Chul Won Seo, Geum Ok Baek, Moon Gyeong Yoon, Hye Ri Ahn, Ju A. Son, Suna Sung, Do Wan Kim, Soon Sun Kim, Hyo Jung Cho, Jae Youn Cheong. Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. Cancers 2020; 12(12) doi: 10.3390/cancers12123819
|
| 53 |
Wenjiao Zeng, Annette S. H. Gouw, Marius C. van den Heuvel, Grietje Molema, Sibrand Poppema, Eric J. van der Jagt, Koert P. de Jong. Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics. Annals of Surgical Oncology 2010; 17(6) doi: 10.1245/s10434-009-0900-z
|
| 54 |
Lui Ng, Ronnie Tung Ping Poon, Roberta Pang. Biomarkers for predicting future metastasis of human gastrointestinal tumors. Cellular and Molecular Life Sciences 2013; 70(19) doi: 10.1007/s00018-013-1266-8
|
| 55 |
Rehab A. Mohamed, Hend M. Maghraby, Eman M. Abd El Salam, Hala M. Nageb, Eman E. Ahmad, Nagwa A. Mohamed. Evaluation of serum endoglin as noninvasive marker in hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2015; 27(1) doi: 10.4103/1110-7782.155832
|